Question 1

Does Citadel Advisors own AVXL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 329,115 shares of AVXL (Anavex Life Sciences), worth $852,408.

Question 2

How many shares of AVXL does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 329,115 shares of AVXL (Anavex Life Sciences).

Question 3

What is Citadel Advisors' AVXL position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' AVXL position is worth $852,408.

Question 4

Is Citadel Advisors buying or selling AVXL?

Accepted Answer

In Q2 2026, Citadel Advisors reduced its AVXL position by 230,320 shares (-41.2%).

Question 5

When did Citadel Advisors first buy AVXL?

Accepted Answer

Citadel Advisors already held AVXL in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	329,115	-41.2%	$852,408	0.0%	$2.59	0
2026-Q1	Increased	559,435	+391.9%	$1.7M	0.0%	$3.07	41
2025-Q4	Decreased	113,739	-41.9%	$404,911	0.0%	$3.56	0
2025-Q3	Decreased	195,725	-39.3%	$1.7M	0.0%	$8.90	0
2025-Q2	Increased	322,205	+679x	$3M	0.0%	$9.22	43
2025-Q1	Decreased	474	-99.8%	$4,067	0.0%	$8.58	0
2024-Q4	Increased	240,906	+843.8%	$2.6M	0.0%	$10.74	42
2024-Q3	Decreased	25,525	-94.3%	$144,982	0.0%	$5.68	0